Probably not, doubtful the market would value RAP's MC at $100M especially after the CR. But we can have best of both were the market still value RAP's MC at $100M after the unsuccessful T/O and no CR needed with the Pfizer funding still going ahead. The pps would more than likely go higher than 11.5c with an excellent quarterly and Pfizer now having to buy on the market to be substantial share holders or withdraw their funding and offer fund for shares to be substantial share holders.
- Forums
- ASX - By Stock
- RAP
- Takeover
Takeover, page-26
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online